Naloxone benzoylhydrazone
Naloxone benzoylhydrazone (NalBzoH) is a mixed agonist/antagonist. Naloxone benzoylhydrazone is a prototypic κ3-opioid receptor agonist, and a partial agonist at the cloned μ and δ opioid receptors, and an antagonist at opioid-like NOP receptors. Naloxone benzoylhydrazone has potently analgesia effect[1][2][3].
Product Specifications
CAS Number
119630-94-3
Product Name Alternative
NalBzoH
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Opioid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/naloxone-benzoylhydrazone.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
O[C@]12[C@@]34C5=C(C(O)=CC=C5C[C@@]2([H])N(CC=C)CC4)O[C@@]3([H])/C(CC1)=N/NC(C6=CC=CC=C6)=O
Molecular Formula
C26H27N3O4
Molecular Weight
445.51
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD10 (CB-CALLA), CF488A conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
